$GENZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENZYME CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENZYME CORP. Get notifications about new insider transactions in GENZYME CORP for free.
Page: < prev 1 2 3 4 5 6 7 ... 10 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | D | 51.52 | 190,000 | 9,788,800 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | M | 0.00 | 22,334 | 0 | 22,333 | |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | M | 0.00 | 42,434 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | U | 74.00 | 1,256 | 92,944 | 0 | 1.3 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | U | 74.00 | 2,371 | 175,454 | 0 | 2.4 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | U | 74.00 | 18,883 | 1,397,342 | 0 | 18.9 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | U | 74.00 | 470,655 | 34,828,470 | 0 | 470.7 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | D | 74.00 | 64,768 | 4,792,832 | 470,655 | 535.4 K to 470.7 K (-12.10 %) |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Buy | M | 0.00 | 22,334 | 0 | 535,423 | 513.1 K to 535.4 K (+4.35 %) |
Apr 06 2011 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Buy | M | 0.00 | 42,434 | 0 | 513,089 | 470.7 K to 513.1 K (+9.02 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | D | 53.47 | 14,700 | 786,009 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | D | 62.98 | 48,500 | 3,054,530 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | D | 58.50 | 69,000 | 4,036,500 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | D | 62.16 | 45,000 | 2,797,200 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | D | 68.48 | 45,000 | 3,081,600 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | D | 58.66 | 42,750 | 2,507,715 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | D | 51.52 | 42,750 | 2,202,480 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | U | 74.00 | 20,671 | 1,529,654 | 0 | 20.7 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | D | 74.00 | 14,500 | 1,073,000 | 20,671 | 35.2 K to 20.7 K (-41.23 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 0.00 | 5,000 | 0 | 35,171 | 30.2 K to 35.2 K (+16.57 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 0.00 | 9,500 | 0 | 30,171 | 20.7 K to 30.2 K (+45.96 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 53.47 | 44,000 | 2,352,680 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 32.52 | 9,225 | 299,997 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 32.52 | 66,300 | 2,156,076 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 41.50 | 830 | 34,445 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 46.24 | 45,000 | 2,080,800 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 43.90 | 57,000 | 2,502,300 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 62.98 | 48,500 | 3,054,530 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 58.50 | 48,500 | 2,837,250 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 62.16 | 24,250 | 1,507,380 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 68.48 | 24,250 | 1,660,640 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 58.66 | 23,038 | 1,351,409 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | D | 51.52 | 23,038 | 1,186,918 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | M | 0.00 | 2,695 | 0 | 2,694 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | M | 0.00 | 5,120 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | U | 74.00 | 221 | 16,354 | 0 | 221 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | U | 74.00 | 37,621 | 2,783,954 | 0 | 37.6 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | D | 74.00 | 7,815 | 578,310 | 37,621 | 45.4 K to 37.6 K (-17.20 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Buy | M | 0.00 | 2,695 | 0 | 45,436 | 42.7 K to 45.4 K (+6.31 %) |
Apr 06 2011 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Buy | M | 0.00 | 5,120 | 0 | 42,741 | 37.6 K to 42.7 K (+13.61 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 27.46 | 4,000 | 109,840 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 53.47 | 29,080 | 1,554,908 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 32.52 | 20,630 | 670,888 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 46.24 | 22,500 | 1,040,400 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 43.90 | 41,000 | 1,799,900 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 62.98 | 35,000 | 2,204,300 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 58.50 | 48,500 | 2,837,250 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 62.16 | 1,608 | 99,953 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 62.16 | 22,642 | 1,407,427 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 68.48 | 45,000 | 3,081,600 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 58.66 | 42,750 | 2,507,715 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 50.02 | 20,000 | 1,000,400 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 30.57 | 15,000 | 458,550 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | D | 51.52 | 60,000 | 3,091,200 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | M | 0.00 | 14,250 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Sell | U | 74.00 | 621 | 45,954 | 0 | 621 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Sell | U | 74.00 | 120 | 8,880 | 0 | 120 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Sell | U | 74.00 | 375 | 27,750 | 0 | 375 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Sell | U | 74.00 | 210 | 15,540 | 0 | 210 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Sell | D | 74.00 | 29,250 | 2,164,500 | 0 | 29.3 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Sell | U | 74.00 | 10,551 | 780,774 | 29,250 | 39.8 K to 29.3 K (-26.51 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Buy | M | 0.00 | 14,250 | 0 | 39,801 | 25.6 K to 39.8 K (+55.77 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Buy | M | 0.00 | 15,000 | 0 | 25,551 | 10.6 K to 25.6 K (+142.17 %) |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 43.30 | 10,000 | 433,000 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 53.47 | 41,000 | 2,192,270 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 32.52 | 13,289 | 432,158 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 32.52 | 80,311 | 2,611,714 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 41.50 | 830 | 34,445 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 46.24 | 45,000 | 2,080,800 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 43.90 | 57,000 | 2,502,300 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 62.98 | 48,500 | 3,054,530 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 58.50 | 48,500 | 2,837,250 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 62.16 | 24,250 | 1,507,380 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 68.48 | 24,250 | 1,660,640 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 58.66 | 23,038 | 1,351,409 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | D | 51.52 | 23,038 | 1,186,918 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | M | 0.00 | 8,083 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | M | 0.00 | 7,679 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Sell | U | 74.00 | 218 | 16,132 | 0 | 218 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Sell | U | 74.00 | 20,830 | 1,541,420 | 0 | 20.8 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Sell | D | 74.00 | 15,762 | 1,166,388 | 20,830 | 36.6 K to 20.8 K (-43.07 %) |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Buy | M | 0.00 | 7,679 | 0 | 36,592 | 28.9 K to 36.6 K (+26.56 %) |
Apr 06 2011 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Buy | M | 0.00 | 8,083 | 0 | 28,913 | 20.8 K to 28.9 K (+38.80 %) |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 53.47 | 30,000 | 1,604,100 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 41.50 | 499 | 20,709 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 46.24 | 22,500 | 1,040,400 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 43.90 | 41,000 | 1,799,900 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 62.98 | 30,000 | 1,889,400 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 58.50 | 30,000 | 1,755,000 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 62.16 | 15,000 | 932,400 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 68.48 | 15,000 | 1,027,200 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 58.66 | 14,250 | 835,905 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | D | 51.52 | 14,250 | 734,160 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | M | 0.00 | 4,750 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Sell | U | 74.00 | 112 | 8,288 | 0 | 112 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Sell | D | 74.00 | 9,750 | 721,500 | 0 | 9.8 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Sell | U | 74.00 | 4,845 | 358,530 | 9,750 | 14.6 K to 9.8 K (-33.20 %) |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Buy | M | 0.00 | 4,750 | 0 | 14,595 | 9.8 K to 14.6 K (+48.25 %) |
Apr 06 2011 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Buy | M | 0.00 | 5,000 | 0 | 9,845 | 4.8 K to 9.8 K (+103.20 %) |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 32.52 | 9,225 | 299,997 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 41.50 | 149 | 6,184 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 46.24 | 10,800 | 499,392 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 43.90 | 24,600 | 1,079,940 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 62.98 | 35,000 | 2,204,300 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 58.50 | 35,000 | 2,047,500 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 62.16 | 17,500 | 1,087,800 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 68.48 | 17,500 | 1,198,400 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 58.66 | 16,625 | 975,223 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | D | 51.52 | 23,038 | 1,186,918 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | M | 0.00 | 5,833 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | M | 0.00 | 5,542 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Sell | U | 74.00 | 779 | 57,646 | 0 | 779 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Sell | U | 74.00 | 779 | 57,646 | 0 | 779 to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Sell | U | 74.00 | 4,947 | 366,078 | 0 | 4.9 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Sell | D | 74.00 | 11,375 | 841,750 | 0 | 11.4 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Sell | U | 74.00 | 5,738 | 424,612 | 11,375 | 17.1 K to 11.4 K (-33.53 %) |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Buy | M | 0.00 | 5,542 | 0 | 17,113 | 11.6 K to 17.1 K (+47.90 %) |
Apr 06 2011 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Buy | M | 0.00 | 5,833 | 0 | 11,571 | 5.7 K to 11.6 K (+101.66 %) |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 53.47 | 24,000 | 1,283,280 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 32.52 | 12,300 | 399,996 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 32.52 | 54,825 | 1,782,909 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 41.50 | 578 | 23,987 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 46.24 | 27,000 | 1,248,480 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 43.90 | 41,000 | 1,799,900 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 62.98 | 35,000 | 2,204,300 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 58.50 | 35,000 | 2,047,500 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 62.16 | 17,500 | 1,087,800 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 68.48 | 17,500 | 1,198,400 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 58.66 | 16,625 | 975,223 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | D | 51.52 | 16,625 | 856,520 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | M | 0.00 | 1,945 | 0 | 1,944 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | M | 0.00 | 3,695 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Sell | U | 74.00 | 12,980 | 960,520 | 0 | 13 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Sell | D | 74.00 | 5,640 | 417,360 | 12,980 | 18.6 K to 13 K (-30.29 %) |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Sell | D | 74.00 | 125 | 9,250 | 18,620 | 18.7 K to 18.6 K (-0.67 %) |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Buy | M | 0.00 | 1,945 | 0 | 18,745 | 16.8 K to 18.7 K (+11.58 %) |
Apr 06 2011 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Buy | M | 0.00 | 3,695 | 0 | 16,800 | 13.1 K to 16.8 K (+28.20 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Canute Scott A | Executive VP | Option Exercise | D | 57.22 | 50,000 | 2,861,000 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Canute Scott A | Executive VP | Option Exercise | D | 51.52 | 42,750 | 2,202,480 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Canute Scott A | Executive VP | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Apr 06 2011 | GENZ | GENZYME CORP | Canute Scott A | Executive VP | Sell | D | 74.00 | 25,000 | 1,850,000 | 0 | 25 K to 0 (-100.00 %) |
Apr 06 2011 | GENZ | GENZYME CORP | Canute Scott A | Executive VP | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Jan 04 2011 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 323 | 0 | 323 | |
Jan 04 2011 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 323 | 0 | 323 | |
Oct 04 2010 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 368 | 0 | 368 | |
Oct 04 2010 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 368 | 0 | 950 |